- /
- Supported exchanges
- / US
- / EIKN.NASDAQ
Eikon Therapeutics, Inc. Common Stock (EIKN NASDAQ) stock market data APIs
Eikon Therapeutics, Inc. Common Stock Financial Data Overview
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs using a platform that permits precise characterization of protein interactions in living cells. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Eikon Therapeutics, Inc. Common Stock data using free add-ons & libraries
Get Eikon Therapeutics, Inc. Common Stock Fundamental Data
Eikon Therapeutics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Eikon Therapeutics, Inc. Common Stock End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eikon Therapeutics, Inc. Common Stock News
New
Jennifer Garner’s Once Upon a Farm Rises Nearly 20% to Wrap Up Busy Week for IPOs
Jennifer Garner’s Sidney Bristow character from the TV show Alias and Elektra in Marvel movies may have faced formidable foes. Garner is a co-founder and investor in the organic baby food company On...
This Mobile App Marketing Firm Is Holding Off an IPO for Now
Liftoff Mobile has postponed its initial public offering, citing market conditions after another day of sharp declines in stocks. “Given current market conditions, we have made a business decision t...
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
MILLBRAE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, innovative medicines to...
Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Eikon Therapeutics, a star-studded biotechnology star...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.